Just Earth News | @justearthnews | 04 May 2021, 01:20 am Print
Pfizer-BioNTech Image: Pixabay
Washinton/Sputnik: The US Food and Drug Administration (FDA) is preparing to approve the Pfizer-BioNTech COVID-19 vaccine for those aged 12 to 15, The New York Times reported, citing federal officials.
The authorization is expected to come early next week, the report said on Monday.
Pfizer announced several weeks ago that none of the adolescents who have received the vaccine during trials have contracted a symptomatic case of COVID-19.
However, plans to vaccinate teens and children, who rarely contract serious cases of the illness, have sparked debate, the report added, as many question whether excess US vaccines could be put to better use on adults in other countries.
- Life expectancy worldwide fell by 1.8 years between 2019 to 2022: WHO
- FAO calls for action amid foot-and-mouth disease outbreaks
- UN says Anthrax outbreak compounds security crisis in DR Congo
- New study finds heart disease deaths worldwide linked to chemical widely used in plastics
- UN health experts believe more action is needed to beat malaria
